• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B

by | Apr 24, 2024 | Publications

Photodermatol Photoimmunol Photomed. 2024 May;40(3):e12965. doi: 10.1111/phpp.12965. NO ABSTRACT PMID:38654582 | DOI:10.1111/phpp.12965

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study

by | Apr 24, 2024 | Publications

Eur J Haematol. 2024 Apr 23. doi: 10.1111/ejh.14214. Online ahead of print. ABSTRACT OBJECTIVES: To characterize the impact of prior exposure and refractoriness to lenalidomide or proteasome inhibitors (PIs) on the effectiveness and safety of...

Association of residential exposure to hazardous air pollutants with risk of non-Hodgkin lymphoma and multiple myeloma

by | Apr 24, 2024 | Publications

Cancer Epidemiol Biomarkers Prev. 2024 Apr 24. doi: 10.1158/1055-9965.EPI-23-1598. Online ahead of print. ABSTRACT BACKGROUND: Certain hazardous air pollutants (HAPs) are known or suspected to pose immunological or cancer risk to humans, but evidence is limited from...

Targeted therapy for multiple myeloma: an overview on CD138-based strategies

by | Apr 24, 2024 | Publications

Front Oncol. 2024 Apr 9;14:1370854. doi: 10.3389/fonc.2024.1370854. eCollection 2024. ABSTRACT Multiple myeloma (MM) is an incurable hematological disease characterized by the uncontrolled growth of plasma cells primarily in the bone marrow. Although its treatment...

Evaluating the HYDRASHIFT 2/4 Daratumumab assay: a powerful approach to assess treatment response in multiple myeloma

by | Apr 17, 2024 | Publications

Clin Chem Lab Med. 2024 Apr 18. doi: 10.1515/cclm-2024-0416. Online ahead of print. ABSTRACT OBJECTIVES: This study evaluates the HYDRASHIFT assay’s effectiveness in mitigating daratumumab interference on serum protein tests during multiple myeloma (MM)...

Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines

by | Apr 17, 2024 | Publications

Ann Hematol. 2024 Apr 17. doi: 10.1007/s00277-024-05733-9. Online ahead of print. ABSTRACT Venous thromboembolism (VTE) poses a significant challenge in the context of multiple myeloma, with an incidence of up to 10% in newly diagnosed patients and varying frequency...
« Older Entries
Next Entries »

Recent Content

  • Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
  • (no title)
  • Efficacy and toxicity of treatment of smoldering multiple myeloma: a systematic review and meta-analysis
  • (no title)
  • Peroxiredoxins as novel indicators in multiple myeloma associated with ferroptosis and immune infiltration
  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT